Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ACADIA PHARMACEUTICALS INC Director's Dealing 2016

Aug 18, 2016

31237_dirs_2016-08-18_7f4d7965-582b-4e7f-be36-bad12d4dd74e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2016-08-16

Reporting Person: HARRIGAN EDMUND (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-08-16 Common Stock P 1000 $32.97 Acquired 1000 Direct